Clinical Trials Logo

Recurrent or Refractory Pediatric Ependymoma clinical trials

View clinical trials related to Recurrent or Refractory Pediatric Ependymoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01032070 Terminated - Clinical trials for Recurrent or Refractory Pediatric Ependymoma

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

PETEY
Start date: September 2010
Phase: Phase 2
Study type: Interventional

This is a phase 2 study to evaluate the efficacy of single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma.